Blood test could spot colon cancer early – 12,000 volunteers needed

NCT ID NCT06059963

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test called Signal-C that looks for DNA fragments in the blood to detect colorectal cancer and advanced precancerous growths. Researchers will enroll 12,000 people aged 45-84 who are at average risk and already scheduled for a routine screening colonoscopy. The goal is to see how accurate the blood test is compared to the colonoscopy results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gastroenterology Consultants of SW Virginia

    RECRUITING

    Raonoke, Virginia, 24014, United States

    Contact